Innovative Eyewear, Inc. (LUCY) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $1.09. It has a SharesGrow Score of 57/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of LUCY = $5,094.48 (+467283.5% from the current price, the stock appears undervalued).
Valuation: LUCY trades at a trailing Price-to-Earnings (P/E) of -0.8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.01.
Financials: revenue is $3M, +59.8%/yr average growth. Net income is $8M (loss), growing at -10.5%/yr. Net profit margin is -285.2% (negative). Gross margin is 21.3% (+29.8 pp trend).
Balance sheet: total debt is $28,488 against $9.1B equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 9.03 (strong liquidity). Debt-to-assets is 0%. Total assets: $10.1B.
Analyst outlook: 1 / 1 analysts rate LUCY as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 100/100 (Pass), Moat 29/100 (Fail), Future 100/100 (Pass), Income 10/100 (Fail).
